EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Engineering Complexity: Advances in 3D Breast Cancer Models for Precision Oncology

Wonwoo Jeong, Sang Jin Lee iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202503104 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Wonwoo Jeong und 1 weiteren Autor:innen. Beteiligte Einrichtung: Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Precision Medicine, Models, Biological. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 195 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDCR NIH HHS, NICHD NIH HHS, National Institute of Child Health and Human Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Engineered in vitro cancer models are essential tools in cancer research, offering controlled microenvironments to study tumor biology and develop personalized therapies. Breast cancer, known for its complexity and high cellular heterogeneity, poses significant challenges in treatment. To address this, patient‐derived in vitro breast cancer models are being used to better predict individual drug responses and guide therapy selection. Recent bioengineering efforts have focused on replicating key features of breast cancer in vitro, such as angiogenesis, tumor cell invasion, heterogeneity, interactions with the tumor microenvironment, and metastatic behavior. Technologies including organoids, microfluidic platforms, and 3D bioprinting technologies have enabled the creation of more biologically and physiologically relevant models. Each system offers specific strengths and limitations, and choosing the right model depends on the research question and desired complexity. This review highlights the current progress in engineering in vitro breast cancer models, comparing their capabilities and discussing innovations aimed at improving their biological accuracy and clinical relevance. Ongoing challenges and future directions are also addressed, with a focus on enhancing model fidelity to native breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsPrecision MedicineModels, BiologicalHumansFemaleTumor MicroenvironmentBioprintingPrinting, Three-DimensionalOrganoidsAnimals

Stichwörter der Autor:innen

Breast cancercancer heterogeneityin vitro modelorganoidstumor microenvironment

Autor:innen und Institutionen

  • Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157, USA.

ORCID-Profile: Sang Jin Lee

Förderung

  • NIDCR NIH HHS
  • NICHD NIH HHS
  • National Institute of Child Health and Human Development
  • National Institute of Dental and Craniofacial Research

Zitieren

APA

Jeong, W., & Lee, S. J. (2026). Engineering Complexity: Advances in 3D Breast Cancer Models for Precision Oncology. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202503104

Vancouver

Jeong W, Lee SJ. Engineering Complexity: Advances in 3D Breast Cancer Models for Precision Oncology. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202503104

BibTeX
@article{Jeong2026,
  author = {Jeong, Wonwoo and Lee, Sang Jin},
  title = {Engineering Complexity: Advances in 3D Breast Cancer Models for Precision Oncology},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202503104}
}
Kostenlos starten →